Signal Transduction Pathways Provide Opportunities to Enhance HDL and apoAI-Dependent Reverse Cholesterol Transport

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|2|352-364

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.2, 2012-02, pp. : 352-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atheroprotective Effects of HDL: Beyond Reverse Cholesterol Transport

By  

Current Drug Targets, Vol. 9, Iss. 3, 2008-03 ,pp. : 196-203

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol Efflux and Reverse Cholesterol Transport: Experimental Approaches

By  

Current Medicinal Chemistry, Vol. 23, Iss. 34, 2016-10 ,pp. : 3883-3908

Bentham Science Publishers

Access to resources Recommend Favorite

Cytosolic Calcium Oscillations in Signal Transduction Pathways

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-08 ,pp. : 353-360

Bentham Science Publishers

Access to resources Recommend Favorite

Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. : 362-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis

By Zingarelli B.   O'Connor M.   Hake P.W.  

European Journal of Pharmacology, Vol. 469, Iss. 1, 2003-05 ,pp. : 183-194

Elsevier

Access to resources Recommend Favorite